Table of Content

1 Study Coverage
1.1 Psoriasis and Atopic Dermatitis Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Psoriasis and Atopic Dermatitis Drugs Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
1.3 Market by Application
1.3.1 Global Psoriasis and Atopic Dermatitis Drugs Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
1.4 Global Psoriasis and Atopic Dermatitis Drugs Market by Region
1.4.1 Global Psoriasis and Atopic Dermatitis Drugs Market by Region: 2019 VS 2024 VS 2030
1.4.2 Global Psoriasis and Atopic Dermatitis Drugs Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global Psoriasis and Atopic Dermatitis Drugs Revenue by Players
2.1.1 Global Psoriasis and Atopic Dermatitis Drugs Revenue by Players (2019-2024)
2.1.2 Global Psoriasis and Atopic Dermatitis Drugs Revenue Market Share by Players (2019-2024)
2.1.3 Global Top 5 and Top 10 Companies by Psoriasis and Atopic Dermatitis Drugs Revenue in 2024
2.2 Global Psoriasis and Atopic Dermatitis Drugs Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global Psoriasis and Atopic Dermatitis Drugs Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 Leo Pharma
3.1.1 Leo Pharma Information
3.1.2 Leo Pharma Overview
3.1.3 Leo Pharma Psoriasis and Atopic Dermatitis Drugs Revenue and Gross Margin (2019-2024)
3.1.4 Leo Pharma Related Developments
3.2 Novartis International AG
3.2.1 Novartis International AG Information
3.2.2 Novartis International AG Overview
3.2.3 Novartis International AG Psoriasis and Atopic Dermatitis Drugs Revenue and Gross Margin (2019-2024)
3.2.4 Novartis International AG Related Developments
3.3 Mylan
3.3.1 Mylan Information
3.3.2 Mylan Overview
3.3.3 Mylan Psoriasis and Atopic Dermatitis Drugs Revenue and Gross Margin (2019-2024)
3.3.4 Mylan Related Developments
3.4 Sanofi
3.4.1 Sanofi Information
3.4.2 Sanofi Overview
3.4.3 Sanofi Psoriasis and Atopic Dermatitis Drugs Revenue and Gross Margin (2019-2024)
3.4.4 Sanofi Related Developments
3.5 Bristol-Myers Squibb Company
3.5.1 Bristol-Myers Squibb Company Information
3.5.2 Bristol-Myers Squibb Company Overview
3.5.3 Bristol-Myers Squibb Company Psoriasis and Atopic Dermatitis Drugs Revenue and Gross Margin (2019-2024)
3.5.4 Bristol-Myers Squibb Company Related Developments
3.6 Anacor Pharmaceutical Inc.
3.6.1 Anacor Pharmaceutical Inc. Information
3.6.2 Anacor Pharmaceutical Inc. Overview
3.6.3 Anacor Pharmaceutical Inc. Psoriasis and Atopic Dermatitis Drugs Revenue and Gross Margin (2019-2024)
3.6.4 Anacor Pharmaceutical Inc. Related Developments
3.7 Encore Dermatology
3.7.1 Encore Dermatology Information
3.7.2 Encore Dermatology Overview
3.7.3 Encore Dermatology Psoriasis and Atopic Dermatitis Drugs Revenue and Gross Margin (2019-2024)
3.7.4 Encore Dermatology Related Developments
3.8 Allergan Plc
3.8.1 Allergan Plc Information
3.8.2 Allergan Plc Overview
3.8.3 Allergan Plc Psoriasis and Atopic Dermatitis Drugs Revenue and Gross Margin (2019-2024)
3.8.4 Allergan Plc Related Developments
3.9 Regeneron Pharmaceuticals, Inc.
3.9.1 Regeneron Pharmaceuticals, Inc. Information
3.9.2 Regeneron Pharmaceuticals, Inc. Overview
3.9.3 Regeneron Pharmaceuticals, Inc. Psoriasis and Atopic Dermatitis Drugs Revenue and Gross Margin (2019-2024)
3.9.4 Regeneron Pharmaceuticals, Inc. Related Developments
3.10 Incyte
3.10.1 Incyte Information
3.10.2 Incyte Overview
3.10.3 Incyte Psoriasis and Atopic Dermatitis Drugs Revenue and Gross Margin (2019-2024)
3.10.4 Incyte Related Developments
3.11 Pfizer
3.11.1 Pfizer Information
3.11.2 Pfizer Overview
3.11.3 Pfizer Psoriasis and Atopic Dermatitis Drugs Revenue and Gross Margin (2019-2024)
3.11.4 Pfizer Related Developments
3.12 Astellas Pharma, Inc.
3.12.1 Astellas Pharma, Inc. Information
3.12.2 Astellas Pharma, Inc. Overview
3.12.3 Astellas Pharma, Inc. Psoriasis and Atopic Dermatitis Drugs Revenue and Gross Margin (2019-2024)
3.12.4 Astellas Pharma, Inc. Related Developments
4 Global Psoriasis and Atopic Dermatitis Drugs Market Insights
4.1 Global Psoriasis and Atopic Dermatitis Drugs Market Revenue 2019-2024
4.2 Global Psoriasis and Atopic Dermatitis Drugs Revenue by Region
4.3 Americas
4.4 Europe
4.5 Asia-Pacific
4.6 Middle East & Africa
5 Market Size by Type
5.1 Global Psoriasis and Atopic Dermatitis Drugs Revenue by Type
5.2 Global Psoriasis and Atopic Dermatitis Drugs Market Size Growth by Type 2019-2024
6 Market Size by Application
6.1 Global Psoriasis and Atopic Dermatitis Drugs Revenue by Application
6.2 Global Psoriasis and Atopic Dermatitis Drugs Market Size Growth by Application 2019-2024
7 Americas
7.1 Americas Psoriasis and Atopic Dermatitis Drugs Market Size by Type
7.1.1 Americas Psoriasis and Atopic Dermatitis Drugs Revenue by Type (2019-2024)
7.1.2 Americas Psoriasis and Atopic Dermatitis Drugs Revenue Share by Type (2019-2024)
7.2 Americas Psoriasis and Atopic Dermatitis Drugs Market Size by Application
7.2.1 Americas Psoriasis and Atopic Dermatitis Drugs Revenue by Application (2019-2024)
7.2.2 Americas Psoriasis and Atopic Dermatitis Drugs Revenue Share by Application (2019-2024)
7.3 Americas Psoriasis and Atopic Dermatitis Drugs Market Size by Country
7.3.1 Americas Psoriasis and Atopic Dermatitis Drugs Revenue by Country (2019-2024)
7.3.2 U.S.
7.3.3 Canada
7.3.4 Mexico
7.3.5 Brazil
7.3.6 Argentina
8 Europe
8.1 Europe Psoriasis and Atopic Dermatitis Drugs Market Size by Type
8.1.1 Europe Psoriasis and Atopic Dermatitis Drugs Revenue by Type (2019-2024)
8.1.2 Europe Psoriasis and Atopic Dermatitis Drugs Revenue Share by Type (2019-2024)
8.2 Europe Psoriasis and Atopic Dermatitis Drugs Market Size by Application
8.2.1 Europe Psoriasis and Atopic Dermatitis Drugs Revenue by Application (2019-2024)
8.2.2 Europe Psoriasis and Atopic Dermatitis Drugs Revenue Share by Application (2019-2024)
8.3 Europe Psoriasis and Atopic Dermatitis Drugs Market Size by Country
8.3.1 Europe Psoriasis and Atopic Dermatitis Drugs Revenue by Country (2019-2024)
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
9 Asia Pacific
9.1 Asia Pacific Psoriasis and Atopic Dermatitis Drugs Market Size by Type
9.1.1 Asia Pacific Psoriasis and Atopic Dermatitis Drugs Revenue by Type (2019-2024)
9.1.2 Asia Pacific Psoriasis and Atopic Dermatitis Drugs Revenue Share by Type (2019-2024)
9.2 Asia Pacific Psoriasis and Atopic Dermatitis Drugs Market Size by Application
9.2.1 Asia Pacific Psoriasis and Atopic Dermatitis Drugs Revenue by Application (2019-2024)
9.2.2 Asia Pacific Psoriasis and Atopic Dermatitis Drugs Revenue Share by Application (2019-2024)
9.3 Asia Pacific Psoriasis and Atopic Dermatitis Drugs Market Size by Region
9.3.1 Asia Pacific Psoriasis and Atopic Dermatitis Drugs Revenue by Region (2019-2024)
9.3.2 China
9.3.3 Japan
9.3.4 South Korea
9.3.5 India
9.3.6 Southeast Asia
9.3.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa Psoriasis and Atopic Dermatitis Drugs Market Size by Type
10.1.1 Middle East and Africa Psoriasis and Atopic Dermatitis Drugs Revenue by Type (2019-2024)
10.1.2 Middle East and Africa Psoriasis and Atopic Dermatitis Drugs Revenue Share by Type (2019-2024)
10.2 Middle East and Africa Psoriasis and Atopic Dermatitis Drugs Market Size by Application
10.2.1 Middle East and Africa Psoriasis and Atopic Dermatitis Drugs Revenue by Application (2019-2024)
10.2.2 Middle East and Africa Psoriasis and Atopic Dermatitis Drugs Revenue Share by Application (2019-2024)
10.3 Middle East and Africa Psoriasis and Atopic Dermatitis Drugs Market Size by Country
10.3.1 Middle East and Africa Psoriasis and Atopic Dermatitis Drugs Revenue by Country (2019-2024)
10.3.2 Turkey
10.3.3 Saudi Arabia
10.3.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 Psoriasis and Atopic Dermatitis Drugs Industry Trends
11.2 Psoriasis and Atopic Dermatitis Drugs Market Drivers
11.3 Psoriasis and Atopic Dermatitis Drugs Market Challenges
11.4 Psoriasis and Atopic Dermatitis Drugs Market Restraints
12 Psoriasis and Atopic Dermatitis Drugs Forecasted Market Size by Type
12.1 Global Psoriasis and Atopic Dermatitis Drugs Forecasted Revenue by Type
12.2 Global Psoriasis and Atopic Dermatitis Drugs Forecasted Market Size Growth by Type 2024-2030
13 Psoriasis and Atopic Dermatitis Drugs Forecasted Market Size by Application
13.1 Global Psoriasis and Atopic Dermatitis Drugs Forecasted Revenue by Application
13.2 Global Psoriasis and Atopic Dermatitis Drugs Forecasted Market Size Growth by Application 2024-2030
14 Global Psoriasis and Atopic Dermatitis Drugs Market Forecasts
14.1 Global Psoriasis and Atopic Dermatitis Drugs Market Revenue Forecasts 2024-2030
14.2 Global Psoriasis and Atopic Dermatitis Drugs Forecasts Revenue by Region
14.3 Americas
14.4 Europe
14.5 Asia-Pacific
14.6 Middle East & Africa
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer